Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Tissue Transplantation01:24

Tissue Transplantation

352
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
352
Inflammatory Bowel Disease V: Surgical Management01:21

Inflammatory Bowel Disease V: Surgical Management

138
Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
138

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Utilization of Paragonix LIVERguardĀ® donor organ transport system for static hypothermic preservation of a multivisceral allograft.

Intestinal Failure (New York, N.Y.)Ā·2026
Same author

Dupilumab Is Safe and Efficacious for Treatment of Eosinophilic Esophagitis and Atopic Dermatitis in Pediatric Liver Transplant Recipients: A Case Series.

Pediatric transplantationĀ·2026
Same author

Development of multicenter consensus care plans for immunosuppression after pediatric liver transplant: Reducing variability, creating comparative efficacy opportunities.

Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation SocietyĀ·2026
Same author

Excellent Outcomes With High-Risk Pediatric Hepatoblastoma: A Detailed Analysis of a Large, Single-Center Experience.

Pediatric transplantationĀ·2026
Same author

A remote intervention to improve medication nonadherence guided by a marker of risk derived from the electronic health records of adolescent transplant recipients.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant SurgeonsĀ·2026
Same author

Mitogen-activated Protein Kinase big Mitogen-activated Kinase-1 Mediates Protection in Liver Ischemia/Reperfusion Injury.

TransplantationĀ·2026

Related Experiment Video

Updated: Jun 18, 2025

Orthotopic Small Bowel Transplantation in Rats
09:16

Orthotopic Small Bowel Transplantation in Rats

Published on: November 6, 2012

14.2K

Intestinal Re-Transplantation.

Carolyn P Smullin1, Robert S Venick2, Elizabeth A Marcus2

  • 1Department of Surgery, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA.

Gastroenterology Clinics of North America
|July 27, 2024
PubMed
Summary
This summary is machine-generated.

Intestinal re-transplantation (re-ITx) is a growing option for patients facing challenges with initial intestinal transplants. Improved immunosuppression and surgical techniques are enhancing outcomes for this complex procedure.

Keywords:
Graft rejectionIntestinal failureIntestinal transplantationRe-transplantation

More Related Videos

Small Bowel Transplantation In Mice
36:30

Small Bowel Transplantation In Mice

Published on: August 20, 2007

14.6K
Tissue Engineering of the Intestine in a Murine Model
08:45

Tissue Engineering of the Intestine in a Murine Model

Published on: December 1, 2012

14.9K

Related Experiment Videos

Last Updated: Jun 18, 2025

Orthotopic Small Bowel Transplantation in Rats
09:16

Orthotopic Small Bowel Transplantation in Rats

Published on: November 6, 2012

14.2K
Small Bowel Transplantation In Mice
36:30

Small Bowel Transplantation In Mice

Published on: August 20, 2007

14.6K
Tissue Engineering of the Intestine in a Murine Model
08:45

Tissue Engineering of the Intestine in a Murine Model

Published on: December 1, 2012

14.9K

Area of Science:

  • Gastroenterology and Hepatology
  • Transplantation Surgery
  • Immunology

Background:

  • Intestinal transplantation (ITx) remains challenging due to high graft rejection and low survival rates compared to other solid organs.
  • Intestinal re-transplantation (re-ITx) is emerging as a critical solution, now representing the fourth most common reason for ITx.
  • Historical advancements in ITx have paved the way for re-ITx as a viable therapeutic option.

Purpose of the Study:

  • To review the current literature on intestinal re-transplantation (re-ITx).
  • To discuss the historical context and evolution of re-ITx.
  • To outline key management considerations and future directions in re-ITx.

Main Methods:

  • Comprehensive literature review of studies on intestinal re-transplantation.
  • Analysis of historical data and trends in ITx and re-ITx.
  • Synthesis of information regarding immunosuppression protocols, surgical techniques, and patient outcomes.

Main Results:

  • Intestinal re-transplantation (re-ITx) is increasingly recognized as a necessary intervention.
  • Improvements in immunosuppression, surgical modifications, and infection monitoring have positively impacted re-ITx outcomes.
  • Despite challenges, re-ITx offers a viable solution for graft failure or complications.

Conclusions:

  • Intestinal re-transplantation is a significant development in managing complex gastrointestinal failure.
  • Ongoing research and clinical advancements are crucial for further improving re-ITx success rates.
  • Future directions should focus on refining protocols and understanding long-term outcomes in re-ITx.